Literature DB >> 1705342

Vagal stimulation reduces the severity of maximal electroshock seizures in intact rats: use of a cuff electrode for stimulating and recording.

J W Woodbury1, D M Woodbury.   

Abstract

J. Zabara showed that repetitive vagal stimulation (VS) prevents or ameliorates convulsive seizures in dogs. We have studied the effects of VS on maximal electroshock seizures (MES) in intact rats: (1) A 5 wire cuff electrode was developed for stimulating and recording from the vagus. Compound action potentials (AP) were recorded and strength-duration curves obtained for A and C fibers. There is a monotonic relationship with a negative slope between heart rate (HR) and AP amplitude. C fibers remain excitable for 25 days after cuff implant. (2) The anticonvulsant efficacy of VS is directly related to the fraction of vagal C fibers stimulated and the frequency of stimulation. (3) The anticonvulsant efficacy of VS has been established using two rat models of human epilepsy. VS abolishes the extensor component of the tonic phase of a MES and shortens or prevents tonic seizures induced by pentylenetetrazol (PTZ). (4) VS appears to act via release of large quantities of the inhibitory mediators GABA and glycine throughout large volumes of the brain. (5) It is rational to test VS in man as a treatment for intractable seizures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705342     DOI: 10.1111/j.1540-8159.1991.tb04053.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

1.  Implantable telemeter for long-term electroneurographic recordings in animals and humans.

Authors:  N de N Donaldson; L Zhou; T A Perkins; M Munih; M Haugland; T Sinkjaer
Journal:  Med Biol Eng Comput       Date:  2003-11       Impact factor: 2.602

2.  Cortical evoked responses following esophageal balloon distension and electrical stimulation in healthy volunteers.

Authors:  S Hollerbach; P Hudoba; D Fitzpatrick; R Hunt; A R Upton; G Tougas
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

3.  Parametric characterization of the rat Hering-Breuer reflex evoked with implanted and non-invasive vagus nerve stimulation.

Authors:  Jesse E Bucksot; Karen Morales Castelan; Samantha K Skipton; Seth A Hays
Journal:  Exp Neurol       Date:  2020-02-03       Impact factor: 5.330

4.  Development of carbamazepine transnasal microemulsion for treatment of epilepsy.

Authors:  Sheetal Porecha Acharya; K Pundarikakshudu; Ashish Panchal; Anita Lalwani
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

5.  Meta-analysis of vagus nerve stimulation treatment for epilepsy: correlation between device setting parameters and acute response.

Authors:  S Ghani; J Vilensky; B Turner; R S Tubbs; M Loukas
Journal:  Childs Nerv Syst       Date:  2015-10-22       Impact factor: 1.475

6.  [Treatment of epilepsy: peripheral and central stimulation techniques].

Authors:  A Schulze-Bonhage; V Coenen
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

7.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448

Review 8.  Stimulation of the nervous system for the management of seizures: current and future developments.

Authors:  Jerome V Murphy; Arunangelo Patil
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  [Electric brain stimulation for epilepsy therapy].

Authors:  C Kellinghaus; T Loddenkemper; G Möddel; F Tergau; J Lüders; P Lüdemann; D R Nair; H O Lüders
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

Review 10.  Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability.

Authors:  E Ben-Menachem; D Revesz; B J Simon; S Silberstein
Journal:  Eur J Neurol       Date:  2015-01-23       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.